ASX - By Stock
|
NEC |
Re:
Ann: FY21 Results Presentation
|
|
edb11
|
15 |
5.2K |
4 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
15
|
5.2K
|
4
|
|
ASX - By Stock
|
APX |
Re:
Massive upside for Appen
|
|
edb11
|
256 |
142K |
3 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
256
|
142K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Key European Patent for Exenatide
|
|
edb11
|
104 |
16K |
4 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
104
|
16K
|
4
|
|
ASX - By Stock
|
EML |
Re:
Ann: Appendix 4E and Annual Report
|
|
edb11
|
83 |
33K |
0 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
83
|
33K
|
0
|
|
ASX - By Stock
|
EML |
Re:
Ann: Appendix 4E and Annual Report
|
|
edb11
|
83 |
33K |
11 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
83
|
33K
|
11
|
|
ASX - By Stock
|
NEC |
Re:
Ann: Notification of Result
|
|
edb11
|
2 |
998 |
0 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
2
|
998
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
edb11
|
506 |
95K |
1 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
506
|
95K
|
1
|
|
ASX - By Stock
|
EML |
Re:
Ann: Appendix 4E and Annual Report
|
|
edb11
|
83 |
33K |
10 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
83
|
33K
|
10
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Key European Patent for Exenatide
|
|
edb11
|
104 |
16K |
3 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
104
|
16K
|
3
|
|
Charts
|
APX |
Re:
APX Charts
|
|
edb11
|
3.8K |
2.0M |
1 |
12/08/21 |
12/08/21 |
Charts
|
3.8K
|
2.0M
|
1
|
|
Charts
|
APX |
Re:
APX Charts
|
|
edb11
|
3.8K |
2.0M |
8 |
12/08/21 |
12/08/21 |
Charts
|
3.8K
|
2.0M
|
8
|
|
ASX - By Stock
|
EML |
Re:
Ann: Injection of funds in PFSUK safeguarding accounts
|
|
edb11
|
24 |
9.6K |
2 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
24
|
9.6K
|
2
|
|
ASX - By Stock
|
STG |
Re:
Ann: Appendix 4C and Quarterly Activites Report Q1
|
|
edb11
|
6 |
1.8K |
2 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
6
|
1.8K
|
2
|
|
ASX - By Stock
|
A2M |
Re:
Ann: Appointment of Chief People & Culture Officer
|
|
edb11
|
31 |
9.7K |
4 |
26/07/21 |
26/07/21 |
ASX - By Stock
|
31
|
9.7K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
edb11
|
13 |
4.1K |
2 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
13
|
4.1K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
edb11
|
13 |
4.1K |
6 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
13
|
4.1K
|
6
|
|
ASX - By Stock
|
A2M |
Re:
Media Updates
|
|
edb11
|
14K |
7.1M |
0 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
14K
|
7.1M
|
0
|
|
Charts
|
APX |
Re:
APX Charts
|
|
edb11
|
3.8K |
2.0M |
0 |
19/07/21 |
19/07/21 |
Charts
|
3.8K
|
2.0M
|
0
|
|
ASX - By Stock
|
STG |
Re:
Ann: Results of Retail Entitlement Offer
|
|
edb11
|
11 |
2.9K |
0 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
11
|
2.9K
|
0
|
|
ASX - By Stock
|
STG |
Re:
Ann: Results of Retail Entitlement Offer
|
|
edb11
|
11 |
2.9K |
1 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
11
|
2.9K
|
1
|
|
Charts
|
APX |
Re:
APX Charts
|
|
edb11
|
3.8K |
2.0M |
3 |
08/07/21 |
08/07/21 |
Charts
|
3.8K
|
2.0M
|
3
|
|
Charts
|
APX |
Re:
APX Charts
|
|
edb11
|
3.8K |
2.0M |
14 |
07/07/21 |
07/07/21 |
Charts
|
3.8K
|
2.0M
|
14
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
edb11
|
146 |
28K |
1 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
146
|
28K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Receives Written Response from FDA on Type C Meeting
|
|
edb11
|
66 |
16K |
0 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
66
|
16K
|
0
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
edb11
|
25K |
12M |
18 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
25K
|
12M
|
18
|
|
ASX - By Stock
|
EML |
Re:
Ann: Investor Briefing and Q3 FY21 Trading Update
|
|
edb11
|
27 |
13K |
0 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
27
|
13K
|
0
|
|
ASX - By Stock
|
STG |
Re:
Ann: Equity Raising to Raise A$20 million
|
|
edb11
|
6 |
2.1K |
0 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
6
|
2.1K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
edb11
|
133 |
31K |
0 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
133
|
31K
|
0
|
|
ASX - By Stock
|
STG |
Re:
Ann: Straker's Year of Transformation Drives Positive Outlook
|
|
edb11
|
4 |
1.2K |
1 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
4
|
1.2K
|
1
|
|
ASX - By Stock
|
EML |
Re:
Ann: Central Bank of Ireland correspondence
|
|
edb11
|
347 |
168K |
3 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
347
|
168K
|
3
|
|
ASX - By Stock
|
EML |
Re:
Ann: Central Bank of Ireland correspondence
|
|
edb11
|
347 |
168K |
5 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
347
|
168K
|
5
|
|
ASX - By Stock
|
APX |
Re:
APX Bottomed out at $12.
|
|
edb11
|
243 |
122K |
1 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
243
|
122K
|
1
|
|
ASX - By Stock
|
APX |
Re:
APX Bottomed out at $12.
|
|
edb11
|
243 |
122K |
0 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
243
|
122K
|
0
|
|
ASX - By Stock
|
APX |
Re:
Ann: Response to ASX Price Query
|
|
edb11
|
130 |
75K |
3 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
130
|
75K
|
3
|
|
ASX - By Stock
|
TYR |
Re:
Ann: Presentation at Macquarie Australia Conference 2021
|
|
edb11
|
8 |
4.2K |
2 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
8
|
4.2K
|
2
|
|
ASX - By Stock
|
NEC |
Re:
Ann: Presentation to Macquarie Conference
|
|
edb11
|
1 |
934 |
0 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
1
|
934
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
edb11
|
133 |
31K |
0 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
133
|
31K
|
0
|
|
ASX - By Stock
|
NEC |
Re:
CEO resignation
|
|
edb11
|
31 |
7.9K |
5 |
10/04/21 |
10/04/21 |
ASX - By Stock
|
31
|
7.9K
|
5
|
|
ASX - By Stock
|
NEC |
Re:
CEO resignation
|
|
edb11
|
31 |
7.9K |
2 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
31
|
7.9K
|
2
|
|
ASX - By Stock
|
EML |
Re:
Ann: EML Acquires Sentenial Ltd & enters the Open Banking Market
|
|
edb11
|
39 |
23K |
5 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
39
|
23K
|
5
|
|
ASX - By Stock
|
EML |
Re:
Ann: EML Acquires Sentenial Ltd & enters the Open Banking Market
|
|
edb11
|
39 |
23K |
4 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
39
|
23K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
edb11
|
19K |
11M |
3 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
19K
|
11M
|
3
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
edb11
|
19K |
11M |
2 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
19K
|
11M
|
2
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
edb11
|
25K |
12M |
2 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
25K
|
12M
|
2
|
|
ASX - By Stock
|
A2M |
Re:
Ann: 1H21 Results Presentation
|
|
edb11
|
333 |
121K |
13 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
333
|
121K
|
13
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
edb11
|
25K |
12M |
0 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
25K
|
12M
|
0
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
edb11
|
25K |
12M |
0 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
25K
|
12M
|
0
|
|
ASX - By Stock
|
A2M |
Re:
Ann: 2020 Annual Meeting presentation (including Outlook)
|
|
edb11
|
179 |
54K |
1 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
179
|
54K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Appendix 4C - quarterly
|
|
edb11
|
102 |
33K |
3 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
102
|
33K
|
3
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Trading Update - H1 FY21
|
|
edb11
|
302 |
154K |
9 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
302
|
154K
|
9
|
|